Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Current Protocols in Pharmacology|June 12, 2012
High throughput functional assays for P2X receptorsMarian T Namovic, Michael F Jarvis, Diana Donnelly-RobertsBritish Journal of Pharmacology|June 30, 2009
Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptorsDiana L Donnelly-Roberts, Marian T Namovic, Ping Han, et al.The Journal of Pharmacology and Experimental Therapeutics|November 25, 2003
Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor (P2X7R)-induced pore formation in human THP-1 cellsDiana L Donnelly-Roberts, Marian T Namovic, Connie R Faltynek, et al.Neuropharmacology|July 8, 2008
[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptorsDiana L Donnelly-Roberts, Marian T Namovic, Bruce Surber, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2008
Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonistsMichael J Morytko, Patrick Betschmann, Kevin Woller, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2008
Synthesis and in vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonistsAlan S Florjancic, Sridhar Peddi, Arturo Perez-Medrano, et al.The Journal of Investigative Dermatology|February 6, 2021
ACT1 Is Required for Murine IL-23-Induced Psoriasiform Inflammation Potentially Independent of E3 Ligase ActivityAlex Lipovsky, Peter F Slivka, Zhi Su, et al.Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonistsWilliam A Carroll, Douglas M Kalvin, Arturo Perez Medrano, et al.Journal of Pharmacological and Toxicological Methods|April 24, 2018
Short-term oral gavage administration of adenine induces a model of fibrotic kidney disease in ratsChang Z Zhu, Kelly J Doyle, Arthur L Nikkel, et al.Bioorganic & Medicinal Chemistry Letters|May 4, 2011
Synthesis and in vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine P2X(7) antagonistsArturo Perez-Medrano, Diana L Donnelly-Roberts, Alan S Florjancic, et al.Pageof 3